Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd.
CSE Index:
Currency:
Cognetivity Neurosciences Ltd. is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA) for use in medical and commercial environments. Cognetivity’s ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity aims to develop the ICA through planned clinical studies to the market in North America and Europe.
Cognetivity Neurosciences Ltd. (CGN)
SEDAR Information
Company Info
Address
Suite 1507, 1030 West Georgia Street
VANCOUVER, BC V6E 2Y3
CanadaPhone
6043405846Email
kevin@calibrecapital.caWebsite
http://www.cognetivity.comListing date
Monday, March 19, 2018Transfer Agent
TSX Trust CompanyCapitalization
Issued & Outstanding:
89556611Reserved for Issuance:
18286051Bulletins
15/03/2018
2018-0316 – New Listing – Cognetivity Neurosciences Ltd. (CGN)
Le 15 mars/March 2018
The common shares of Cognetivity Neurosciences Ltd. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the listing date.
